1-4 of 4
Huiqing LIU
Close
Sort by
Journal Articles

Short-Term Efficacy and Safety of Blinatumomab in Early Postinduction Intensification Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia

Yanming Li, Peijing Qi, Ying Wu, Jiaole Yu, Yuanyuan Zhang, Huiqing Liu, Bei Hou, Jie Yang, Huyong Zheng, Tianyou Wang, Ruidong Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5901.
https://doi.org/10.1182/blood-2023-188669
Published: 2023
Journal Articles

Application of High-Throughput Sequencing in the Diagnosis of Inherited Immune-Thrombocytopenia from Children Chronic/Refractory ITP

Ma Jingyao, MD, Zhenping Chen, PhDMD, Huiqing LIU, Jialu Zhang, Hao GU, Runhui Wu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 86.
https://doi.org/10.1182/blood-2019-126771
Published: 2019
Journal Articles

Cell-of-Origin Subtype Prediction of Diffuse Large B-Cell Lymphoma Using Gene Expression and Proteomic Data

Huiqing Liu, PhD, Jin Lu, PhD, Zhiwan Dong, PhD, Hao Liu, PhD, Edward Salinas, MSc, Sherry Owens, PhD, Michael A. Pratta, MSc, Michael F. Smith, PhD, Hiroomi Tada, MD PhD, Robert C Newton, PhD, Timothy Burn, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1712.
https://doi.org/10.1182/blood-2018-99-116949
Published: 2018
Journal Articles

Gene Expression Profiling of Paired Pre- and Post-Prednisolone (PRED) BM Samples from Childhood ALL Identifies Robust Signatures for PRED Response and Eventual Outcome.

Yi Lu, Huiqing Liu, Ying Xu, Pei Lin Koh, Ariffin Hany, Limsoon Wong, Allen Eng Juh Yeoh
Journal: Blood
Blood (2006) 108 (11): 222.
https://doi.org/10.1182/blood.V108.11.222.222
Published: 2006